Production of monoclonal antibodies in eggs of transgenic avians

转基因禽蛋中单克隆抗体的生产

基本信息

  • 批准号:
    14350434
  • 负责人:
  • 金额:
    $ 10.62万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

Transgenic chickens have been proposed as a transgenic bioreactor for the production of recombinant proteins. To date, although various procedures for generating transgenic avians have been reported, the expression of a transgene at a commercially feasible level has not been attained. We used a replication-defective pantropic retroviral vector based on Moloney murine leukemia virus(MoMLV) pseudotyped with vesicular stomatitis virus G protein(VSV-G) for gene introduction to avian embryos. For the generation of transgenic chickens producing monoclonal antibodies, we firstly constructed a retroviral vector plasmid for the expression of a single-chain antibody fragment(scFv), derived from an anti-prion protein monoclonal antibody, fused with the Fc region of human IgG1, as a model antibody. We steadily generated transgenic chickens (GO) by injecting a concentrated retroviral vector into the heart of developing embryos after 55 h incubation and followed by embryo culture to hatch. The GO ch … More ickens expressed the transgene product in their serum and eggs at high levels (~5.6 mg/ml) throughout the breeding period. The expression level in egg white corresponds to almost one tenth that of ovalbumin, a major protein in egg white, and more than equivalent to that of lysozyme. Furthermore, we could obtain G1 and G2 transgenic progeny derived from a GO chicken. The transgenic progeny also expressed the transgene product in their serum and eggs. Next, we constructed a retroviral vector for the production of a chimeric anti-CD2 antibody, in which the bicistronic expression of H-and L-chain genes of the antibody was mediated by an internal ribosomal entry site(IRES) sequence derived from encephalomyocarditis virus(EMCV). The viral vector was injected to chicken embryos after 55 h incubation to generate GO transgenic chickens. The chickens hatched expressed anti-CD2 antibody in the serum and eggs. This system demonstrates the reality of a transgenic chicken bioreactor for the commercial production of monoclonal antibodies. Less
转基因鸡已被提议作为生产重组蛋白的转基因生物反应器。迄今为止,尽管已经报道了用于产生转基因禽类的各种方法,但是还没有达到商业上可行的水平的转基因表达。我们使用了复制缺陷型泛嗜性逆转录病毒载体的基础上莫洛尼鼠白血病病毒(MoMLV)假型水泡性口炎病毒G蛋白(VSV-G)的基因导入禽胚胎。为了获得产生单克隆抗体的转基因鸡,我们首先构建了用于表达单链抗体片段(scFv)的逆转录病毒载体质粒,所述单链抗体片段(scFv)来源于抗朊蛋白单克隆抗体,与人IgG 1的Fc区融合,作为模型抗体。我们通过将浓缩的逆转录病毒载体注射到孵育55小时后发育中的胚胎的心脏中,然后通过胚胎培养孵化来稳定地产生转基因鸡(GO)。GO CH ...更多信息 在整个繁殖期间,ickens在其血清和卵中以高水平(~5.6mg/ml)表达转基因产物。在卵白色中的表达水平几乎相当于卵清蛋白(卵白色中的主要蛋白质)的十分之一,并且超过溶菌酶的表达水平。此外,我们可以获得G1和G2代转基因后代的GO鸡。转基因后代也在其血清和卵中表达转基因产物。接下来,我们构建了一个逆转录病毒载体的嵌合抗CD2抗体的生产,其中的H-和L-链基因的抗体的双顺反子表达介导的内部核糖体进入位点(IRES)序列来自脑心肌炎病毒(EMCV)。将病毒载体注射到孵育55 h后的鸡胚中以产生GO转基因鸡。孵化出的雏鸡血清和蛋中均表达抗CD2抗体。该系统展示了用于商业化生产单克隆抗体的转基因鸡生物反应器的现实。少

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
上平正道, 西島謙一, 飯島信司: "金の卵を産むニワトリをつくる-トランスジェニック鳥類を使った有用タンパク質の生産"化学と生物. 41(2). 70-72 (2003)
Masamichi Kamihira、Kenichi Nishijima、Shinji Iijima:“创造能下金蛋的鸡——利用转基因鸟类生产有用的蛋白质”,化学与生物学 41(2) (2003)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Production of pharmaceutical proteins by transgenic avian
转基因禽类生产药用蛋白
Animal Cell Technology : Basic & Applied Aspects, Vol.13(Production of pharmaceutical proteins by transgenic avian)
动物细胞技术:基础
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A.Hotta;K.Ono;S.Mizuarai;K.Yamaguchi;K.Nishijima;M.Kamihira;S.Iijima
  • 通讯作者:
    S.Iijima
Transgenic birds for the production of recombinant proteins
用于生产重组蛋白的转基因鸟类
M.Kamihira, K.Nishijima, S.Iijima: "Recent Progress of Biochemical and Biomedical Engineering in Japan (Chapter14 : Transgenic Bird for the Production of Recombinant Proteins)"Springer(印刷中). (2004)
M.Kamihira、K.Nishijima、S.Iijima:“日本生化和生物医学工程的最新进展(第 14 章:用于生产重组蛋白的转基因鸟)”Springer(出版中)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAMIHIRA Masamichi其他文献

KAMIHIRA Masamichi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAMIHIRA Masamichi', 18)}}的其他基金

Development ofgenetically modified hepatic cells with induced high liver functions for bioartificial liver systems
用于生物人工肝系统的诱导高肝功能的转基因肝细胞的开发
  • 批准号:
    23650289
  • 财政年份:
    2011
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Development of transgenic avian platform for the production of biologics
开发用于生产生物制品的转基因禽类平台
  • 批准号:
    20360376
  • 财政年份:
    2008
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of oviduct specific promoter system for transgenic chicken bioreactors
转基因鸡生物反应器输卵管特异性启动子系统的开发
  • 批准号:
    17360396
  • 财政年份:
    2005
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A tissue engineering approach for liver tissue organization in vitro
体外肝组织组织的组织工程方法
  • 批准号:
    12650784
  • 财政年份:
    2000
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of novel gene delivery system
新型基因传递系统的开发
  • 批准号:
    12555227
  • 财政年份:
    2000
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of efficient gene transfection procedure for animal cells
开发动物细胞高效基因转染程序
  • 批准号:
    10650783
  • 财政年份:
    1998
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
  • 批准号:
    10892414
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
  • 批准号:
    10932479
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
  • 批准号:
    10761372
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
  • 批准号:
    10933280
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
  • 批准号:
    10696698
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
  • 批准号:
    10726173
  • 财政年份:
    2023
  • 资助金额:
    $ 10.62万
  • 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
  • 批准号:
    2212947
  • 财政年份:
    2022
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
  • 批准号:
    22K19387
  • 财政年份:
    2022
  • 资助金额:
    $ 10.62万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了